MKM Partners Doesn't See NCE Status or a Quick Sale for Amarin (AMRN)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amarin (AMRN) Dips Following FDA Orange Book Update
January 18, 2013 2:35 PM ESTAmarin Corp Plc (NASDAQ: AMRN) shares are pressured following an update to the FDA's Orange Book.
The Book had Amarin's Vascepa with "no unexpired exclusivity for this product," though no NCE decision was made.
Shares are down 7.5 percent Friday afternoon.... More
